This information can help identify patterns and guide discussions with your healthcare team about potential adjustments to your treatment plan
Along with reduced appetite, users often feel more energized and focused, making it easier to maintain an active lifestyle and reach their weight loss goals. The FDA approved phentermine in adults aged 17 and older, typically for those with a BMI of 30 or higher, or 27 or higher with weight-related conditions
Whether youve heard about it from friends or stumbled upon it online, semaglutide is a hot topicand for good reason
Catalysts 7(8):238 Ospina-Romero M, Cannegieter SC, den Heijer M, Doggen CJM, Rosendaal FR, Lijfering WM (2018) Hyperhomocysteinemia and risk of first venous thrombosis: the influence of (unmeasured) confounding factors
There are other gray areas
The authorisation further strengthens Novo Nordisk's position in the increasingly competitive obesity market, while highlighting growing industry interest in alternative delivery formats for peptide-based medicines